CHECKMATE-816

NCT02998528 📎

Regimen

Experimental
neoadjuvant nivo + chemo (3 cycles)
Control
neoadjuvant chemo

Population

Resectable stage IB-IIIA NSCLC

Key finding

pCR 24.0% vs 2.2%; EFS HR 0.63 (0.43-0.91); first phase III neoadj IO for NSCLC

Source: PMID 35403841

Timeline

  • Enrollment start: 2017-03-04 📎

Guideline citations

  • NCCN NSCLC Version 5.2026 (p.164)
  • CSCO NSCLC 2025 ⚠️ OCR source